Mary Bird Perkins Cancer Center is located in Baton Rouge, LA. The organization was established in 1969. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2022, Mary Bird Perkins Cancer Center employed 504 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Mary Bird Perkins Cancer Center is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Mary Bird Perkins Cancer Center generated $112.9m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 16.0% each year . All expenses for the organization totaled $112.7m during the year ending 06/2022. While expenses have increased by 17.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO IMPROVE SURVIVORSHIP AND LESSEN THE BURDEN OF CANCER THROUGH EXPERT TREATMENT, COMPASSIONATE CARE, EARLY DETECTION, RESEARCH, AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PATIENT CARE ACTIVITIES:MARY BIRD PERKINS CANCER CENTER (MBPCC) IS THE LEADING CANCER CARE ORGANIZATION IN LOUISIANA PROVIDING STATE-OF-THE-ART RADIATION THERAPY TREATMENT AND COMPREHENSIVE CANCER CARE TO PATIENTS REGARDLESS OF ABILITY TO PAY. MBPCC, THROUGH ITS SEVEN LOCATIONS, SERVES 18 PARISHES (COUNTIES) ACROSS SOUTHEAST LOUISIANA AND PORTIONS OF SOUTHWEST MISSISSIPPI, HOME TO APPROXIMATELY 1.5 MILLION PEOPLE. DURING JULY 1, 2021 JUNE 30, 2022, MBPCC PROVIDED APPROXIMATELY 44,398 RADIATION THERAPY TREATMENTS TO 7,814 PATIENTS SEEKING CANCER CARE. DURING THE SAME PERIOD, MBPCC PROVIDED CONTINUING CANCER CARE THROUGH 5,618 FOLLOW-UP PATIENT VISITS FOLLOWING THERAPY COMPLETION. PATIENTS RECEIVING CARE DURING JULY 1, 2021 JUNE 30, 2022 WERE PROVIDED ACCESS TO NATIONAL AND LOCAL CLINICAL RESEARCH TRIALS INVESTIGATING WAYS TO BETTER PREVENT, DETECT, DIAGNOSE, AND TREAT CANCER. MBPCC IS ACCREDITED BY THE AMERICAN COLLEGE OF RADIOLOGY AND THE AMERICAN COLLEGE OF SURGEONS - TWO NATIONALLY RECOGNIZED ACCREDITING ORGANIZATIONS. DURING JULY 1, 2021 JUNE 30, 2022, APPROXIMATELY 29% OF ITS GROSS PATIENT REVENUE WAS DERIVED FROM PATIENT PARTICIPATION IN EITHER THE MEDICARE OR MEDICAID PROGRAM. MBPCC IS THE SOLE PROVIDER OF RADIATION THERAPY SERVICES TO PATIENTS OF LSU HEALTH CARE SERVICES AND LALLIE KEMP REGIONAL MEDICAL CENTER, BOTH PUBLIC HOSPITALS SERVING THE MEDICALLY INDIGENT POPULATION IN SOUTHEAST LOUISIANA. COSTS INCURRED IN JULY 1, 2021 JUNE 30, 2022 TO PROVIDE CARE IN EXCESS OF REIMBURSEMENT RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS, WERE $5,926,000. MBPCC ALSO PROVIDED $14,021 OF DISCOUNTS AND WAIVED COLLECTION EFFORTS UNDER ITS PATIENT DISCOUNT POLICY FOR THOSE QUALIFYING PATIENTS.
CANCER PROGRAM ACTIVITIES:MBPCC BELIEVES COMMUNITIES BENEFIT WHEN THE EXPERTISE OF LOCAL HOSPITALS, PHYSICIANS, SUPPORT ORGANIZATIONS SOLELY FOCUSED ON CANCER ARE LINKED TOGETHER TO FORM A COMPREHENSIVE CANCER PROGRAM. CANCER PATIENTS BENEFIT FROM THE CONVENIENCE OF HIGH-QUALITY, ADVANCED MEDICAL TREATMENT AND CARE IN ONE LOCATION WITHIN THEIR COMMUNITY AT LESS COST TO BOTH ORGANIZATIONS. TO DATE, MBPCC HAS IMPLEMENTED THREE COMPREHENSIVE CANCER PROGRAM MODELS AND ASSUMED CERTAIN RESPONSIBILITIES FOR DEVELOPING AND DELIVERING THE CANCER CARE CONTINUUM TO THE LOCAL COMMUNITY. SERVICES INCLUDE CANCER PREVENTION EDUCATION, EARLY DETECTION, FREE CANCER SCREENING, AND TRANSPORTATION ASSISTANCE. AS WELL AS UNIQUE PROGRAMS OF PUBLIC AND PROFESSIONAL EDUCATION, CLINICAL TRIALS AND CANCER RESEARCH. DURING JULY 1, 2021 THROUGH JUNE 30, 2022, THE CANCER PROGRAMS SCREENED 5,426 PEOPLE AT 264 FREE CANCER SCREENING EVENTS FOR BREAST, PROSTATE, ORAL, COLON AND SKIN CANCERS. SINCE 2002, OVER 107,000 PEOPLE THROUGHOUT SOUTHEAST LOUISIANA HAVE BEEN SCREENED FOR CANCER AT NO COST TO PARTICIPANTS. JULY 1, 2021 THROUGH JUNE 30, 2022, 662 (12%) OF THE SCREENED PARTICIPANTS WERE NAVIGATED DUE TO ABNORMAL FINDINGS AND 37 WERE DIAGNOSED WITH CANCER. FOR THE UNINSURED, GRANTS AND DONATIONS PROVIDED FUNDING FOR FOLLOW-UP TESTS, SUCH AS COLONOSCOPIES AND BIOPSIES. EDUCATIONAL PROGRAMS REGARDING CANCER WERE CONDUCTED FOR 7,518 PEOPLE ATTENDING COMMUNITY EVENTS. EACH CANCER PROGRAM, INCLUDING OUTREACH, SURVIVORSHIP AND CLINICAL RESEARCH, RELIES ON GRANTS AND PHILANTHROPY TO FUND THESE SERVICES.
MEDICAL PHYSICS RESIDENCY PROGRAM:MBPCC PLAYS A SIGNIFICANT ROLE IN THE MARY BIRD PERKINS CANCER CENTER LOUISIANA STATE UNIVERSITY (MBPCC-LSU) MEDICAL PHYSICS AND HEALTH PHYSICS PROGRAM. THIS ACADEMIC PROGRAM PROVIDES DIDACTIC INSTRUCTION AND CLINICAL AND RESEARCH TRAINING TO THE LSU MS AND PHD GRADUATE STUDENTS IN MEDICAL PHYSICS. GRADUATES OF THIS PROGRAM BECOME MEDICAL PHYSICISTS. THE LSU MEDICAL PHYSICS ACADEMIC PROGRAM IS ONE OF THE LARGEST IN THE COUNTRY TRAINING MEDICAL PHYSICISTS TO SERVE CANCER PROGRAMS NATIONWIDE. ALTHOUGH MUCH OF THE MBPCC MEDICAL PHYSICISTS' BUDGET SUPPORTS ITS PHD STAFF (LSU ADJUNCT FACULTY) TO PERFORM TRANSLATIONAL MEDICAL PHYSICS RESEARCH, IT ALSO INCLUDES TEACHING IN THE MBPCC - LSU MEDICAL PHYSICS PROGRAM AND MENTORING OF GRADUATE STUDENT RESEARCH. GRADUATE STUDENTS WORK TO COMPLETE OVER 20 RESEARCH PROJECTS EVERY YEAR IMPACTING CANCER TREATMENT WORLDWIDE. IN ADDITION, MBPCC PROVIDES STUDENT CLASSROOM SPACE, STUDENT OFFICES, TEACHING LABS, RESEARCH LABS, CLINICAL TRAINING FACILITIES, ADMINISTRATIVE SUPPORT AND SUPPLIES. MBPCC HAS NUMEROUS RESEARCH GRANTS, WHICH PROVIDE FUNDING FOR ITS MEDICAL PHYSICISTS, SUPPORT STAFF, AND POSTDOCTORAL FELLOWS, AS WELL AS LSU GRADUATE RESEARCH ASSISTANTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Thomas J Adamek Chair | OfficerTrustee | 1 | $0 |
Cordell Haymon Vice Chair | OfficerTrustee | 1 | $0 |
Mark Dearman Director | Trustee | 1 | $0 |
Art E Favre Immediate Past Chair | OfficerTrustee | 1 | $0 |
Cathy Giering Director | Trustee | 1 | $0 |
Gerald T Goss Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Southeast Louisiana Radiation Oncology G Contract Physicians | 6/29/22 | $5,991,629 |
The Chartist Group Llc Consulting | 6/29/22 | $525,840 |
Taylor Porter Brooks & Phillips Llp Attorney | 6/29/22 | $438,230 |
La Specialty Service Llc Medical Supplies/medical Devices | 6/29/22 | $347,642 |
Kathleen C Perleydecode Digital Market Advertising | 6/29/22 | $308,250 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $143,145 |
Related organizations | $640,728 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $10,048,112 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $10,831,985 |
Total Program Service Revenue | $97,036,990 |
Investment income | $484,903 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $3,536,617 |
Net Gain/Loss on Asset Sales | $236,309 |
Net Income from Fundraising Events | -$53,976 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $112,882,708 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $2,638,059 |
Compensation of current officers, directors, key employees. | $1,509,290 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $28,181,600 |
Pension plan accruals and contributions | $518,745 |
Other employee benefits | $1,263,049 |
Payroll taxes | $1,002,313 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $66,750 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,706,220 |
Advertising and promotion | $1,257,788 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $225,408 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $796,764 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $3,706,541 |
Insurance | $666,219 |
All other expenses | $6,719,200 |
Total functional expenses | $112,723,138 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $8,644,573 |
Savings and temporary cash investments | $14,242,187 |
Pledges and grants receivable | $4,015,091 |
Accounts receivable, net | $29,455,478 |
Loans from Officers, Directors, or Controlling Persons | $17,837 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $10,800,000 |
Inventories for sale or use | $3,646,897 |
Prepaid expenses and deferred charges | $2,154,462 |
Net Land, buildings, and equipment | $37,910,976 |
Investments—publicly traded securities | $486,873 |
Investments—other securities | $13,115,142 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $5,641,559 |
Total assets | $130,131,075 |
Accounts payable and accrued expenses | $16,994,715 |
Grants payable | $0 |
Deferred revenue | $19,440,000 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $27,670,339 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,069,289 |
Total liabilities | $65,174,343 |
Net assets without donor restrictions | $62,842,430 |
Net assets with donor restrictions | $2,114,302 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $130,131,075 |